how to invest in glp 1 1: Just a wonder drug or a lifesaver for millions? Where to invest in GLP-1

The SURMOUNT-OSA trials revealed that Tirzepatide dramatically reduced obstructive sleep apnea severity by finding that the drug decreased case patients' apnea-hypopnea index (AHI), a measure of breathing interruptions, by an estimated 2024 events per hour more than controls, depending on whether patients were using positive airway pressure (PAP) therapy at baseline

Highly Effective for Absorption Issues: Injections are the gold standard for people with pernicious anemia, severe digestive disorders, or a history of gastric surgery

All other data, including immunoblots, GSH and AA, were also analysed for statistical significance using a two-tailed unpaired Students t -test unless stated otherwise

BPC 157() ,